tiprankstipranks
Trending News
More News >
C-MER Eye Care Holdings Limited (HK:3309)
:3309
Hong Kong Market

C-MER Eye Care Holdings Limited (3309) Financial Statements

Compare
1 Followers

C-MER Eye Care Holdings Limited Financial Overview

C-MER Eye Care Holdings Limited's market cap is currently HK$2.22B. The company's EPS TTM is HK$-0.111; its P/E ratio is 33.92; C-MER Eye Care Holdings Limited is scheduled to report earnings on April 1, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total RevenueHK$ 1.91BHK$ 1.92BHK$ 1.73BHK$ 1.11BHK$ 699.54M
Gross ProfitHK$ 527.62MHK$ 618.96MHK$ 365.34MHK$ 309.44MHK$ 163.65M
Operating IncomeHK$ -66.16MHK$ 119.34MHK$ -24.43MHK$ -2.33MHK$ -13.72M
EBITDAHK$ 209.18MHK$ 359.88MHK$ 194.31MHK$ 177.80MHK$ 126.69M
Net IncomeHK$ -135.16MHK$ 62.00MHK$ -21.88MHK$ 21.86MHK$ -6.25M
Balance Sheet
Cash & Short-Term InvestmentsHK$ 467.25MHK$ 557.42MHK$ 698.51MHK$ 442.36MHK$ 553.93M
Total AssetsHK$ 2.72BHK$ 2.75BHK$ 2.90BHK$ 1.96BHK$ 1.63B
Total DebtHK$ 437.79MHK$ 362.99MHK$ 452.49MHK$ 471.69MHK$ 244.97M
Net DebtHK$ 14.71MHK$ -149.77MHK$ -192.21MHK$ 85.03MHK$ -308.97M
Total LiabilitiesHK$ 830.24MHK$ 755.35MHK$ 903.45MHK$ 618.63MHK$ 331.98M
Stockholders' EquityHK$ 1.75BHK$ 1.85BHK$ 1.87BHK$ 1.33BHK$ 1.29B
Cash Flow
Free Cash FlowHK$ 123.58MHK$ 245.30MHK$ 100.63MHK$ 19.18MHK$ -233.39M
Operating Cash FlowHK$ 283.12MHK$ 361.15MHK$ 191.86MHK$ 148.41MHK$ 104.03M
Investing Cash FlowHK$ -174.72MHK$ -245.37MHK$ -210.65MHK$ -392.72MHK$ -157.94M
Financing Cash FlowHK$ -194.92MHK$ -242.88MHK$ 281.64MHK$ 78.10MHK$ 322.37M
Currency in HKD

C-MER Eye Care Holdings Limited Earnings and Revenue History

C-MER Eye Care Holdings Limited Debt to Assets

C-MER Eye Care Holdings Limited Cash Flow

C-MER Eye Care Holdings Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis